Phase 3 Lymphatic Malformation Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Lymphatic Malformations
Novartis Pharmaceuticals232 enrolled56 locationsNCT05948943
Recruiting
Phase 3
Systematic Approach for Children With Orbital Malformation With Sirolimus Use
Orbital Lymphatic Malformation
Ain Shams University30 enrolled1 locationNCT07378657
Recruiting
Phase 2Phase 3
Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations
Lymphatic Malformation
West China Hospital150 enrolled1 locationNCT06673290